CCR5 genotype and resistance to vertical transmission of HIV-1

被引:39
|
作者
Philpott, S
Burger, H
Charbonneau, T
Grimson, R
Vermund, SH
Visosky, A
Nachman, S
Kovacs, A
Tropper, P
Frey, H
Weiser, B
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] SUNY Stony Brook, Stony Brook, NY 11794 USA
[4] Univ Alabama, Birmingham, AL USA
[5] Univ So Calif, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA
[6] St Lukes Roosevelt Med Ctr, New York, NY USA
[7] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[8] St Johns Riverside Hosp, Yonkers, NY USA
来源
关键词
HIV-1; CCR5; vertical transmission;
D O I
10.1097/00126334-199907010-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A human gene has been identified that affects susceptibility to HIV-1 infection. The gene codes for CCR5, the coreceptor for macrophage-tropic strains of HIV-1. Individuals who are homozygous for a deleted, mutant form of the gene, Delta 32, display a high degree of natural resistance to sexual and parenteral transmission of HIV-1. To investigate whether Delta 32 plays a role in vertical transmission, we determined the CCR5 genotype of 552 children born to infected mothers in the United States and correlated the genotypes with HIV-1 infection status. Of these children, 13% were white, 30% Latino, and 56% African American, reflecting the ethnic makeup of infected women in the United States. The Delta 32 gene frequency varied among these groups, ranging from 0.08 in whites to 0.02 in both Latinos and African Americans. Approximately 27% of the children in each ethnic group were infected. Four children were identified as Delta 32 homozygotes, two uninfected whites (3.77%) and two uninfected Latinos (1.68%). None of the infected children displayed the Delta 32 homozygous genotype. Among Latinos and whites, the number of uninfected children who carried the homozygous Delta 32 mutation was significantly greater than that predicted by the Hardy-Weinberg equilibrium (p < .001 for Latinos, p = .044 for whites). This association was noted in Latino and white children whose mothers were either treated or untreated with zidovudine, These data document the occurrence of the homozygous Delta 32 genotype among children of HIV-1-infected mothers and suggest that this mutant genotype may confer protection from mother-to-child transmission of HIV-1, They also suggest that sexual, parenteral, and vertical transmission all involve processes that use CCR5 as a coreceptor for primary HIV-1 infection. Therefore, blocking the CCR5 receptor may provide an additional strategy to prevent HIV-1 vertical transmission.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 50 条
  • [1] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [2] CCR5, vertical transmission of HIV-1, and disease progression
    Bailey, AJ
    Newell, ML
    De Rossi, A
    Giaquinto, C
    Iasci, A
    Ravizza, M
    Garcia-Rodriguez, MC
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (02): : 211 - 212
  • [3] Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1
    Mandl, CW
    Aberle, SW
    Henkel, JH
    Puchhammer-Stöckl, E
    Heinz, FX
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1998, 55 (01) : 51 - 55
  • [4] CCR5 genotype and the clinical course of HIV-1 infection
    Scribner, CL
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (09) : 780 - 780
  • [5] CCR-5 genotype and sexual transmission of HIV-1
    O'Brien, TR
    Padian, NS
    Hodge, T
    Goedert, JJ
    O'Brien, SJ
    Carrington, M
    [J]. AIDS, 1998, 12 (04) : 444 - 445
  • [6] CCR5 genotype and HIV-1 infection in perinatally-exposed infants
    Mas, A
    Español, T
    Heredia, A
    Pedraza, MA
    Hernandez, M
    Caragol, I
    Fernando, M
    Bertran, JM
    Alcami, J
    Soriano, V
    [J]. JOURNAL OF INFECTION, 1999, 38 (01) : 9 - 11
  • [7] Association between CCR5 genotype and the clinical course of HIV-1 infection
    Husman, AMD
    Koot, M
    Cornelissen, M
    Keet, IPM
    Brouwer, M
    Broersen, SM
    Bakker, M
    Roos, MTL
    Prins, M
    deWolf, F
    Coutinho, RA
    Miedema, F
    Goudsmit, J
    Schuitemaker, H
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) : 882 - +
  • [8] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [9] The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
    Nelson L. Michael
    Leslie G. Louie
    Amy L. Rohrbaugh
    Kathleen A. Schultz
    Debora E. Dayhoff
    Carol E. Wang
    Haynes W. Sheppard
    [J]. Nature Medicine, 1997, 3 : 1160 - 1162
  • [10] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. AIDS, 2008, 22 (16) : 2212 - 2214